Impact of age on the cumulative risk of transformation in patients with chronic myelomonocytic leukaemia

In older patients with chronic myelomonocytic leukaemia (CMML) and limited life expectancy due to age and or comorbidities, it is particularly important to consider the risk of transformation for individualised treatment decisions. There is limited information on potential differences between younge...

Descripción completa

Detalles Bibliográficos
Autores principales: Machherndl‐Spandl, Sigrid, Jäger, Eva, Barna, Agnes, Gurbisz, Michael, Marschon, Renate, Graf, Temeida, Graf, Elmir, Geissler, Christoph, Hoermann, Gregor, Nösslinger, Thomas, Pfeilstöcker, Michael, Bettelheim, Peter, Zach, Otto, Weltermann, Ansgar, Heibl, Sonja, Thaler, Josef, Zebisch, Armin, Sill, Heinz, Stauder, Reinhard, Webersinke, Gerald, Kusec, Rajko, Ulsperger, Ernst, Schneeweiss, Bruno, Öhler, Leopold, Germing, Ulrich, Valent, Peter, Tüchler, Heinz, Geissler, Klaus
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2021
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8480146/
https://www.ncbi.nlm.nih.gov/pubmed/33998054
http://dx.doi.org/10.1111/ejh.13647

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8480146/
https://www.ncbi.nlm.nih.gov/pubmed/33998054
http://dx.doi.org/10.1111/ejh.13647

Ejemplares similares